G42 Healthcare, a subsidiary of Abu Dhabi-based technology company Group 42 (G42), announced today it has signed a Memorandum of Understanding with NanoScent, an Israeli company specialised in scent reading technologies, to explore collaborations in the development, validation, distribution and manufacturing of Scent Check - a revolutionary solution capable of detecting suspected cases of Covid-19 from a sample of exhaled nasal air. The Scent Check device detects a combination of ...